Sirona Biochem Corp. (CVE:SBM – Get Free Report) traded down 18.8% on Monday . The stock traded as low as C$0.07 and last traded at C$0.07. 112,944 shares were traded during trading, an increase of 44% from the average session volume of 78,445 shares. The stock had previously closed at C$0.08.
Sirona Biochem Stock Performance
The firm’s 50 day simple moving average is C$0.07 and its 200-day simple moving average is C$0.06. The company has a market capitalization of C$16.69 million, a price-to-earnings ratio of -6.50 and a beta of -0.03. The company has a debt-to-equity ratio of 219.21, a quick ratio of 2.41 and a current ratio of 0.34.
Sirona Biochem Company Profile
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.
Featured Stories
- Five stocks we like better than Sirona Biochem
- 5 Top Rated Dividend Stocks to Consider
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 2 Drone Stocks Surging from Increased Media Attention
- Business Services Stocks Investing
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
